Krystal Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
KRYS Key Statistics
Stock Snapshot
As of today, Krystal Biotech(KRYS) shares are valued at $261.41. The company's market cap stands at 7.58B, with a P/E ratio of 39.21.
On 2026-01-11, Krystal Biotech(KRYS) stock moved within a range of $252.92 to $267.48. With shares now at $261.41, the stock is trading +3.4% above its intraday low and -2.3% below the session's peak.
Trading volume for Krystal Biotech(KRYS) stock has reached 349.33K, versus its average volume of 271.45K.
The stock's 52-week range extends from a low of $122.80 to a high of $267.48.
The stock's 52-week range extends from a low of $122.80 to a high of $267.48.
KRYS News
In early January 2026, Krystal Biotech reported a positive interim update from the highest-dose cohort of its Phase 1 CORAL-1 study of inhaled gene therapy KB40...
Claim 70% Off TipRanks Premium Krystal Biotech ( (KRYS) ) just unveiled an update. On January 8, 2026, Krystal Biotech reported positive interim results from...
Krystal Biotech (KRYS) announced an interim clinical update from the highest dose cohort of CORAL-1, the company’s multi-center, dose escalation Phase 1 study e...
Analyst ratings
100%
of 12 ratingsMore KRYS News
Citi upgraded Krystal Biotech (KRYS) to Buy from Neutral with a price target of $309, up from $198. The firm sees opportunities in SMID-cap biotech heading into...